Key Points
- COO Laurent Moll sold 990 shares on April 10 at an average price of $19.90 for proceeds of $19,701, but still directly owns 279,982 shares (about $5.57M), a 0.35% reduction in his stake.
- Arteris recently beat quarterly estimates (EPS of -$0.05 vs. -$0.08 and revenue $20.14M vs. $18.55M) and the stock trades near its 12‑month high (~$20.17) with a market cap of roughly $917M and a negative P/E of -24.6.
- Analyst sentiment is mixed (two Buys, one Hold, one Sell) with a consensus price target of $20.17, while several hedge funds including Nuveen, Goldman Sachs, Westerly and Granahan materially increased positions, leaving institutional ownership at about 64.36%.
Arteris, Inc. (NASDAQ:AIP - Get Free Report) COO Laurent Moll sold 990 shares of the firm's stock in a transaction that occurred on Friday, April 10th. The shares were sold at an average price of $19.90, for a total value of $19,701.00. Following the completion of the sale, the chief operating officer directly owned 279,982 shares of the company's stock, valued at $5,571,641.80. This represents a 0.35% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Arteris Price Performance
AIP opened at $20.17 on Wednesday. The business has a 50 day simple moving average of $16.14 and a 200-day simple moving average of $15.35. The stock has a market capitalization of $917.13 million, a P/E ratio of -24.60 and a beta of 1.43. Arteris, Inc. has a 12 month low of $5.64 and a 12 month high of $20.40.
Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings results on Thursday, February 12th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.03. The business had revenue of $20.14 million during the quarter, compared to analyst estimates of $18.55 million. Research analysts anticipate that Arteris, Inc. will post -0.73 EPS for the current year.
Analyst Ratings Changes
AIP has been the subject of several recent analyst reports. Northland Securities set a $24.00 price target on Arteris in a report on Friday, February 13th. Wall Street Zen raised Arteris from a "hold" rating to a "buy" rating in a report on Saturday, March 21st. Rosenblatt Securities reissued a "buy" rating and issued a $20.00 price target on shares of Arteris in a report on Friday, February 13th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a report on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $20.17.
Check Out Our Latest Research Report on Arteris
Hedge Funds Weigh In On Arteris
Several hedge funds and other institutional investors have recently bought and sold shares of AIP. Westerly Capital Management LLC raised its holdings in Arteris by 109.6% during the third quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company's stock worth $14,392,000 after purchasing an additional 745,000 shares during the last quarter. Nuveen LLC raised its holdings in Arteris by 872.3% during the fourth quarter. Nuveen LLC now owns 737,281 shares of the company's stock worth $11,428,000 after purchasing an additional 661,454 shares during the last quarter. Goldman Sachs Group Inc. raised its holdings in Arteris by 144.7% during the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company's stock worth $15,696,000 after purchasing an additional 598,840 shares during the last quarter. Granahan Investment Management LLC raised its holdings in Arteris by 725.7% during the third quarter. Granahan Investment Management LLC now owns 621,625 shares of the company's stock worth $6,278,000 after purchasing an additional 546,341 shares during the last quarter. Finally, Informed Momentum Co LLC acquired a new position in Arteris during the fourth quarter worth $5,755,000. 64.36% of the stock is owned by institutional investors and hedge funds.
About Arteris
(
Get Free Report)
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
